Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00221-7/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=268172138&_hsenc=p2ANqtz-8ZKt8UNYq9S30RZbgW2K3UxduNAQ9RZWPcnvYBVWor2cgrAHwx3nVSh5Wk0CeYTaPx1iLxsNJwU2qNnRHQz1C-zV7GHw&utm_content=268146206&utm_source=hs_email